Alzamend Neuro, Inc.

NASDAQ:ALZN

1.19 (USD) • At close December 24, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Revenue 000.0760000000000000000000000000000.1180.11800
Cost of Revenue 00.0130.0130.0130.0130.0130.0050.0050.0050.007000000000000000000000.0590.0590.0590.059
Gross Profit 0-0.0130.063-0.013-0.013-0.013-0.005-0.005-0.005-0.007000000000000000000000.0590.059-0.059-0.059
Gross Profit Ratio 000.8330000000000000000000000000000.50.500
Reseach & Development Expenses 0.3110.2070.1831.9091.9972.3661.6482.8891.5331.3761.6610.8741.750.9160.2930.2340.4750.3090.2430.4270.20.20.4710.4711.3791.3790.1570.1570.0050.0050.1380.13800
General & Administrative Expenses 0.7430.7560.6670.7510.9050.9121.412.5351.3261.662.2121.6831.8341.390.9270.8810.8231.0091.0170.8460.7460.7460.4660.4660.1880.1880.1660.1660.1070.1070.2180.2180.2530.253
Selling & Marketing Expenses 0.3040-0.235-0.01300.2470.2470.2470.2470.001000.00100000000000000.0040.0040.0110.0110.0940.0940.0710.071
SG&A 1.0470.7560.6670.7380.9051.161.6572.5351.5731.662.2121.6831.8341.390.9270.8810.8231.0091.0170.8460.7460.7460.4660.4660.1880.1880.170.170.1170.1170.3130.3130.3240.324
Other Expenses 0000000000000000000000000000000000
Operating Expenses 1.3580.9620.852.6472.9023.5263.3055.4243.1063.0363.8732.5573.5842.3061.221.1161.2981.3181.2591.2730.9460.9460.9370.9371.5671.5670.3270.3270.1230.1230.450.450.3240.324
Operating Income -1.358-0.962-0.85-2.66-2.902-3.526-3.305-5.424-3.106-3.036-3.873-2.557-3.584-2.306-1.22-1.116-1.298-1.318-1.259-1.273-0.946-0.946-0.937-0.937-1.567-1.567-0.327-0.327-0.123-0.123-0.391-0.391-0.383-0.383
Operating Income Ratio 00-11.169000000000000000000000000000-3.301-3.30100
Total Other Income Expenses Net -0.003-0.012-0.001-0.002-0.004-0.002-0.001-0.002-0.004-0.0020.003-0.016-0.016-0.014-0.037-0.003-0.0560.0020.0020.0030.0040.0040.0310.0310.0420.042-0-0-0.016-0.016-0.008-0.008-0.003-0.003
Income Before Tax -1.362-0.974-0.852-2.662-2.906-3.528-3.306-5.426-3.11-3.037-3.869-2.573-3.6-2.32-1.257-1.119-1.354-1.317-1.257-1.271-0.941-0.941-0.906-0.906-1.525-1.525-0.327-0.327-0.139-0.139-0.399-0.399-0.386-0.386
Income Before Tax Ratio 00-11.188000000000000000000000000000-3.371-3.37100
Income Tax Expense 00-0-00-0.031-0.0070.0020.0040.002-0.0030.033-1.28-2.306-1.22-1.05-1.298-1.317-1.2710.0030.0040.0040.0310.0310.0420.042-0-0-0.016-0.016-0.008-0.008-0.003-0.003
Net Income -1.362-0.974-0.852-2.662-2.906-3.528-3.306-5.428-3.114-3.039-3.866-2.573-3.6-2.32-1.257-1.119-1.354-1.317-1.257-1.271-0.941-0.941-0.906-0.906-1.525-1.525-0.327-0.327-0.139-0.139-0.399-0.399-0.386-0.386
Net Income Ratio 00-11.188000000000000000000000000000-3.371-3.37100
EPS -0.4-1.25-1.24-3.78-4.43-5.38-5.12-8.29-4.8-4.68-6.6-4.1-5.78-4.12-2.55-2.33-2.82-2.74-2.62-2.67-1.99-1.99-2.04-2.04-4.5-4.5-0.85-0.85-0.63-0.63-1.83-1.83-2.34-2.34
EPS Diluted -0.4-1.25-1.24-3.77-4.43-5.38-5.12-8.28-4.79-4.68-6.6-4.1-5.78-4.11-2.55-2.32-2.81-2.73-2.62-2.67-1.99-1.99-2.04-2.04-4.49-4.49-0.85-0.85-0.63-0.63-1.83-1.83-2.33-2.33
EBITDA -1.345-0.95-0.837-2.647-2.889-3.513-3.3-5.418-3.101-3.028-3.869-2.557-3.584-2.306-1.220-1.298000.0030.0040.0040.0310.0310.0420.042-0-0-0.016-0.016-0.008-0.008-0.003-0.003
EBITDA Ratio 00-11.002000000000000000000000000000-0.07-0.0700